{
    "clinical_study": {
        "@rank": "18393", 
        "brief_summary": {
            "textblock": "To investigate whether instantaneous wave-Free Ratio(iFR)/Fractional Flow Reserve(FFR)\n      guided treatment strategy makes the postulated treatment strategy by Coronary Angiogram(CAG)\n      guide change and to analyze the cost-effectiveness of its dual diagnosis.\n\n      To investigate difference between SYNTAX score evaluated CAG and functional SYNTAX score\n      evaluated physiological assessment of coronary stenosis and its clinical effectiveness."
        }, 
        "brief_title": "Japan Study of Distal Evaluation of Functional Significance of Intra-arterial Stenosis Narrowing Effect", 
        "condition": "Coronary Artery Disease", 
        "condition_browse": {
            "mesh_term": [
                "Coronary Artery Disease", 
                "Myocardial Ischemia", 
                "Coronary Disease"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age>=20 years old.\n\n          -  Patient who can understand informed consent of the clinical study and signed the\n             consent.\n\n          -  Patient who is adaptable to CAG and/or coronary revascularization\n\n          -  Patient who has evaluated stenotic lesion (stenosis>50% in visual judgment) by CAG at\n             main epicardial vessel and its branch or who suspected to have it.\n\n        Exclusion Criteria:\n\n          -  Patient with known contraindications to Adenosine Triphosphate(ATP) and/or papaverine\n             hydrochloride\n\n          -  Target vessel diameter<=2.0mm\n\n          -  Lesion with Chronic Total Occlusion(CTO) (registration allowed if other branch has\n             stenosis more than 50% in visual judgment)\n\n          -  Patient with temporary/permanent artificial pacemaker implantation, left bundle\n             branch block, second-degree and third-degree atrioventricular block.\n\n          -  Acute Myocardial Infarction(AMI) patient\n\n          -  Patient who is disqualified for FFR and coronary revascularization by the\n             investigator.\n\n          -  Lesion is disqualified for Percutaneous Coronary Intervention(PCI) by the\n             investigator.\n\n          -  Patient who has critical valvular disease of heart. (moderate or severe Aortic valve\n             stenosis(AS)/Aortic Regurgitation(AR)/Mitral Stenosis(MS)/Mitral Regurgitation(MR)\uff09\n\n          -  Patient with a prior Coronary Artery Bypass Graft(CABG) on target vessel.\n\n          -  Patient with severe renal dysfunction. (serum creatinine>=2.0mg/dl)\n\n          -  Patient on hemodialysis.\n\n          -  Body weight>=200kg\n\n          -  Patient who needs ventricular assist device to ensure hemodynamic stability (heart\n             rate<50/min, SBP\uff1c90mmHg)\n\n          -  Patient who expects to live less than 2 years at the registration\n\n          -  Patient with contraindications to an antithrombotic therapy or an anticoagulant\n             therapy.\n\n          -  Patient who is poor compliance with drug treatment.\n\n          -  Patient who is allergic to contrast agent.\n\n          -  Left Ventricular Ejection Fraction(LVEF)>=30%\n\n          -  Patient who has the history of PCI with Drug-Eluting Stent(DES) in recent 3 months\n             before registration.\n\n          -  Patient who has the history of PCI with Bare Metal Stent(BMS) or Plain Old Balloon\n             Atherectomy(POBA) in recent 1 year before registration.\n\n          -  Patient who has possibility of pregnancy, under breast-feeding and positive pregnancy\n             test in 14days prior to the PCI.\n\n          -  Patients with inadequacy to join this clinical study.\n\n          -  Patient who has been enrolled any other clinical study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "20 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patient who is adaptable to CAG and/or coronary revascularization"
            }
        }, 
        "enrollment": {
            "#text": "500", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 28, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02002910", 
            "org_study_id": "J-DEFINE"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "iFR", 
            "FFR", 
            "Medical Economy", 
            "physiological assessment", 
            "SYNTAX score"
        ], 
        "lastchanged_date": "December 2, 2013", 
        "location": {
            "contact": {
                "last_name": "Masato Nakamura, M.D", 
                "phone": "+81-3-3468-1251"
            }, 
            "facility": {
                "address": {
                    "city": "Minato", 
                    "country": "Japan", 
                    "state": "Tokyo", 
                    "zip": "105-0013"
                }, 
                "name": "NPO Associations for Establishment of Evidence in Interventions"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Japan"
        }, 
        "number_of_groups": "1", 
        "official_title": "Japan Study of Distal Evaluation of Functional Significance of Intra-arterial Stenosis Narrowing Effect", 
        "overall_contact": {
            "last_name": "Masato Nakamura, M.D", 
            "phone": "+81-3-3468-1251"
        }, 
        "overall_official": {
            "last_name": "Masato Nakamura, M.D", 
            "role": "Study Chair"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Japan: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "To evaluate the healthcare cost-effectiveness in QALY\uff08Quality Adjusted Life Year\uff09converted by Japanese functional score ; Quality of Life(QOL) questionnaire (EQ-5D) and the cost postulated by CAG strategy with its iFR/FFR hybrid strategy.\nTo collect the healthcare cost related MACCE at the timing of 6 and 12 months FU point. (Included emergency visit) To collect QOL questionnaire (EQ-5D) at the timing of just after the treatment and 12 months follow up point.", 
                "measure": "Medical economy", 
                "safety_issue": "Yes", 
                "time_frame": "1 year  after the procedure"
            }, 
            {
                "description": "Alteration in treatment protocol. Change in SYNTAX score.", 
                "measure": "Physiological assessment", 
                "safety_issue": "Yes", 
                "time_frame": "baseline pocedure"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02002910"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "MACCE include all-cause death, cerebrovascular accident(CVA), myocardial infarction(MI), and repeat revascularization.", 
                "measure": "Incidence of major adverse cardiac and cerebrovascular events(MACCE)", 
                "safety_issue": "Yes", 
                "time_frame": "1year after the pocedure"
            }, 
            {
                "description": "Area under receiver-operating characteristic curve(ROC) Classification agreement between iFR and FFR in this registry, Demonstrated using the area under the receiver-operating characteristic curve(FFR cut-off 0.8 or 0.75).", 
                "measure": "correlated analysis", 
                "safety_issue": "No", 
                "time_frame": "baseline pocedure"
            }, 
            {
                "description": "Treatment categorization disagreements of iFR and FFR are analyzed by multi-variable analysis processing to calculate Characteristic factors.", 
                "measure": "evaluation of variance", 
                "safety_issue": "No", 
                "time_frame": "beseline procedure"
            }
        ], 
        "source": "Associations for Establishment of Evidence in Interventions", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Associations for Establishment of Evidence in Interventions", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "December 2013"
    }
}